Published in Curr Pharm Des on January 01, 2012
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Increased intra-individual variability of cognitive processing in subjects at risk mental state and schizophrenia patients. PLoS One (2013) 1.44
Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study. Soc Psychiatry Psychiatr Epidemiol (2015) 1.44
Attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.24
The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol Psychiatry (2013) 1.11
The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull (2014) 1.11
Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull (2013) 1.10
The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort. World Psychiatry (2014) 1.07
Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res (2013) 1.06
Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull (2013) 1.04
White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study. Schizophr Bull (2013) 1.04
A stratified model for psychosis prediction in clinical practice. Schizophr Bull (2014) 0.97
An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry (2016) 0.94
Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res (2013) 0.90
Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions. Schizophr Bull (2015) 0.89
A pilot study of cognitive training in clinical high risk for psychosis: initial evidence of cognitive benefit. Schizophr Res (2014) 0.88
Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up. PLoS One (2014) 0.86
Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics. Curr Neuropharmacol (2012) 0.83
Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis. PLoS One (2015) 0.83
How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis. Trends Cogn Sci (2015) 0.83
Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds. Transl Psychiatry (2014) 0.83
Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis. Eur Arch Psychiatry Clin Neurosci (2015) 0.82
Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia. Schizophr Bull (2013) 0.82
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat (2015) 0.82
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry (2016) 0.82
Early Childhood IQ Trajectories in Individuals Later Developing Schizophrenia and Affective Psychoses in the New England Family Studies. Schizophr Bull (2015) 0.81
The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. Psychiatry Res (2012) 0.81
Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis. Schizophr Res (2013) 0.81
Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. Transl Psychiatry (2013) 0.80
Developmental mechanisms in the prodrome to psychosis. Dev Psychopathol (2013) 0.79
Ten year neurocognitive trajectories in first-episode psychosis. Front Hum Neurosci (2013) 0.79
Examining associations between psychosis risk, social anhedonia, and performance of striatum-related behavioral tasks. J Abnorm Psychol (2015) 0.79
Is pharmacological intervention necessary in prodromal schizophrenia? Shanghai Arch Psychiatry (2012) 0.79
Cannabis use and cognitive functions in at-risk mental state and first episode psychosis. Psychopharmacology (Berl) (2013) 0.79
Clinical high risk and first episode schizophrenia: auditory event-related potentials. Psychiatry Res (2014) 0.78
Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. Psychiatry Res (2014) 0.78
Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res (2016) 0.77
Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis. Schizophr Bull (2016) 0.77
Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance. PLoS One (2015) 0.76
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia. Schizophr Bull (2016) 0.76
The prodrome and clinical risk for psychotic disorders. Child Adolesc Psychiatr Clin N Am (2013) 0.76
Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study. BMC Psychiatry (2015) 0.76
Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis. Early Interv Psychiatry (2015) 0.76
Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats. Dev Neurosci (2015) 0.76
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res (2012) 0.76
Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians. Harv Rev Psychiatry (2016) 0.75
Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample. Schizophr Res (2015) 0.75
The early identification of psychosis: can lessons be learnt from cardiac stress testing? Psychopharmacology (Berl) (2015) 0.75
Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia. Schizophr Bull (2015) 0.75
How should we intervene in psychosis risk syndromes? Shanghai Arch Psychiatry (2013) 0.75
Neuropsychological profile in adult schizophrenia measured with the CMINDS. Psychiatry Res (2015) 0.75
Neural correlates of the preserved inhibition of return in schizophrenia. PLoS One (2015) 0.75
Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis. Schizophr Res (2016) 0.75
Working with Asian American youth at clinical high risk for psychosis: a case illustration. J Nerv Ment Dis (2013) 0.75
Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis. Eur Arch Psychiatry Clin Neurosci (2014) 0.75
Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome. Transl Psychiatry (2017) 0.75
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Synthesis, characterization and biological activity of triorganotin 2-phenyl-1,2,3-triazole-4-carboxylates. J Inorg Biochem (2005) 3.98
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry (2008) 3.29
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull (2007) 3.28
Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology (2009) 3.27
Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry (2008) 3.27
Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 3.17
Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry (2005) 3.08
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull (2006) 2.53
Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44
Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30
Hierarchical genetic organization of human cortical surface area. Science (2012) 2.28
Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci (2005) 2.25
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Genetic and environmental influences on the size of specific brain regions in midlife: the VETSA MRI study. Neuroimage (2009) 1.94
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry (2013) 1.87
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality. Brain Dev (2005) 1.81
North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res (2012) 1.79
MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am J Psychiatry (2002) 1.72
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev (2003) 1.71
Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci (2012) 1.69
Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry (2004) 1.66
Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res (2006) 1.62
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry (2008) 1.59
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry (2006) 1.55
Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex (2007) 1.51
Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry (2002) 1.49
Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry (2005) 1.47
Genetic influences on cortical regionalization in the human brain. Neuron (2011) 1.46
MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliability. Neuroimage (2005) 1.44
Cortical thickness is influenced by regionally specific genetic factors. Biol Psychiatry (2009) 1.44
A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res (2011) 1.44
Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol Psychiatry (2006) 1.44
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
Decreased absolute amygdala volume in cocaine addicts. Neuron (2004) 1.41
Fronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging study. Biol Psychiatry (2005) 1.41
Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry (2005) 1.40
Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder. Dev Neurosci (2009) 1.39
Medial prefrontal cortical activation during working memory differentiates schizophrenia and bipolar psychotic patients: a pilot FMRI study. Schizophr Res (2011) 1.38
Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder. Biol Psychiatry (2006) 1.36
Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.35
Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res (2012) 1.32
Emotion processing in persons at risk for schizophrenia. Schizophr Bull (2008) 1.31
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron (2008) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives. Schizophr Bull (2008) 1.24
Sex differences in prefrontal cortical brain activity during fMRI of auditory verbal working memory. Neuropsychology (2005) 1.23
Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff". Schizophr Bull (2006) 1.23
Sex differences in the functional neuroanatomy of working memory in adults with ADHD. Am J Psychiatry (2009) 1.21
The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res (2009) 1.21
The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr Res (2004) 1.21
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review. Cogn Neuropsychiatry (2012) 1.19
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry (2008) 1.19
Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study. Schizophr Res (2013) 1.19
Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods. Harv Rev Psychiatry (2006) 1.18
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia. Schizophr Res (2010) 1.17
Impaired intellect and memory: a missing link between genetic risk and schizophrenia? Arch Gen Psychiatry (2010) 1.15
The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res (2010) 1.15
Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr Bull (2007) 1.15
Heterogeneity of schizophrenia: a study of individual neuropsychological profiles. Schizophr Res (2004) 1.13
Genetic and environmental contributions to regional cortical surface area in humans: a magnetic resonance imaging twin study. Cereb Cortex (2011) 1.13
A comparison of heritability maps of cortical surface area and thickness and the influence of adjustment for whole brain measures: a magnetic resonance imaging twin study. Twin Res Hum Genet (2012) 1.13
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Human cerebral cortex: a system for the integration of volume- and surface-based representations. Neuroimage (2006) 1.12
Portland identification and early referral: a community-based system for identifying and treating youths at high risk of psychosis. Psychiatr Serv (2010) 1.11
Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry (2005) 1.11
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr Res (2010) 1.11
Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis (2012) 1.11
Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. Br J Psychiatry (2006) 1.11
Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biol Psychiatry (2004) 1.09
Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin study. Neuroimage (2010) 1.09
Paternal age as a risk factor for schizophrenia: how important is it? Schizophr Res (2009) 1.09
Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.07
Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age. J Alzheimers Dis (2011) 1.05
An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry (2005) 1.05
Neural substrates of impaired sensorimotor timing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2010) 1.05